[1]Rudolph CD, Mazur LJ, Liptak GS, Baker RD, Boyle JT, Colletti RB, et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition [J]. J Pediatr Gastroenterol Nutr, 2001, 32(Suppl 2):S1-S31.
[2]Hassall E. Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children [J]. J Pediatr, 2005, 146(3 Suppl):S3-S12.
[3]EI-Serag HB, Gilger M, Carter J, Genta RM, Rabeneck L. Childhood GERD is a risk factor for GERD in adolescents and young adults [J]. Am J Gastroenterol, 2004, 99(5):806-812.
[4]Gold BD. Is gastroesophageal reflux disease really a life-long disease: do babies who regurgitate grow up to be adults with GERD complications? [J]. Am J Gastroenterol, 2006,101(3):641-644.
[6]Hu FZ, Donfack J, Ahmed A, Dopico R, Johnson S, Post JC, et al. Fine mapping a gene for pediatric gastroesophageal reflux on human chromosome 13q14 [J]. Hum Genet, 2004,114(6):562-572.
[8]Orenstein SR. Tests to assess symptoms of gastroesophageal reflux in infants and children [J]. J Pediatr Gastroenterol Nutr, 2003, 37(Suppl 1):S29-S32.
[9]Kleinman L, Rothman M , Strauss R, Orenstein SR, Nelson S, Vandenplas Y, et al. The infant gastroesophageal reflux questionnaire revised: development and validation as an evaluative instrument [J]. Clin Gastroenterol Hepatol, 2006, 4(5):588-596.
[10]Aggarwal S, Mittal SK, Kalra KK, Rajeshwari K, Gondal R. Infant gastroesophageal reflux disease score: reproducibility and validity in a developing country [J]. Trop Gastroenterol, 2004, 25(2):96-98.
[11]Deal L, Gold BD, Gremse DA, Winter HS, Peters SB, Fraga PD, et al. Age-specific questionnaires distinguish GERD symptom frequency and severity in infants and young children: development and initial validation [J].J Pediatr Gastroenterol Nutr, 2005, 41(2):178-185.
[13]Dranove JE. Focus on diagnosis: new technologies for the diagnosis of gastroesophageal reflux disease [J]. Pediatr Rev, 2008, 29(9):317-320.
[14]Condino A,Sondheimer J,Pan Z,Gralla J, Perry D, O′Connor JA.Evaluation of infantile acid and nonacid gastroesophageal reflux using combined pH monitoring and impedance measurement [J]. J Pediatr Gastroenterol Nutr, 2006, 42(1):16-21.
[15]Lopez-Alonso M, Moya MJ, Cabo JA, Ribas J, del Carmen Macías M, Silny J. Twenty-four hour esophageal impedance-pH monitoring in healthy preterm neonates : rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux [J]. Pediatrics, 2006,118(2) :e299-e308.
[16]Lee SH, Jang JY, Yoon IJ, Kim KM. Usefulness of multichannel intraluminal impedance-pH metry in children with suspected gastroesophageal reflux disease [J]. Korean J Gastroenterol, 2008, 52(1):9-15.
[17]Croffie JM, Fitzgerald JF, Molleston JP, Gupta SK, Corkins MR, Pfefferkorn MD, et al. Accuracy and tolerability of the Bravo catheter-free pH capsule in patients between the ages of 4 and 18 years [J]. J Pediatr Gastroenterol Nutr, 2007, 45(5):559-563.
[18]Gunnarsdóttir A, Stenstr-m P, Arnbj-rnsson E. 48-hour wireless oesophageal pH-monitoring in children: are two days better than one? [J]. Eur J Pediatr Surg, 2007, 17(6):378-381.
[19]Orel R, Markovic S. Bile in the esophagus: a factor in the pathogenesis of reflux esophagitis in children [J]. J Pediatr Gastroenterol Nutr, 2003, 36(2):266-273.
[20]Oh DS, Hagen JA, Fein M, Bremner CG, Dunst CM, Demeester SR, et al. The impact of reflux composition on mucosal injury and esophageal function [J]. J Gastrointest Surg, 2006, 10(6):787-797.
[21]Jiang MZ, Chen J, Chen FB, Yu J, Liang J, Zhang Y, et al.Bile and acid reflux in the pathogenesis of reflux oesophagitis in children [J]. J Paediatr Child Health, 2009, 45(1-2):64-67.
[22]Farina R, Pennisi F, La Rosa M, Puglisi C, Mazzone G, Riva G, et al. Contrast-enhanced colour-Doppler sonography versus pH-metry in the diagnosis of gastro-oesophageal reflux in children [J].Radiol Med, 2008, 113(4):591-598.
[23]Argon M, Duygun U, Daglioz G, Omür O, Demir E, Aydogdu S. Relationship between gastric emptying and gastroesophageal reflux in infants and children [J]. Clin Nucl Med, 2006, 31(5):262-265.
[24]Chitkara DK, Fortunato C, Nurko S.Esophageal motor activity in children with gastro-esophageal reflux disease and esophagitis [J]. J Pediatr Gastroenterol Nutr, 2005, 40(1):70-75.
[25]Soyer T, Karnak I, Tanyel FC, Senocak ME, Ciftci AO, Büyü-kpamukcu N. The use of pH monitoring and esophageal manometry in the evaluation of results of surgical therapy for gastroesophageal reflux disease [J]. Eur J Pediatr Surg, 2007, 17(3):158-162.
[26]Gilger MA, EI-Serag HB, Gold BD, Dietrich CL, Tsou V, McDuffie A,et al. Prevalence of endoscopic findings of erosive esophagitis in children: a population-based study [J]. J Pediatr Gastroenterol Nutr, 2008, 47(2):141-146.
[27]Corvaglia L, Rotatori R, Ferlini M, Aceti A, Ancora G, Faldella G. The effect of body positioning on gastroesophageal reflux in premature infants: evaluation by combined impedance and pH monitoring [J].J Pediatr, 2007,151(6):591-596.
[28]van Wijk MP, Benninga MA, Dent J, Lontis R, Goodchild L, McCall LM, et al. Effect of body position changes on postprandial gastroesophageal reflux and gastric emptying in the healthy premature neonate [J].J Pediatr, 2007, 151(6):585-590.
[29]Simren M, Silng J, Holloway R, Tack J, Janssens J, Sifrim D. Relevance of ineffective oesophageal motility during oesophageal acid clearance [J]. Gut, 2003, 52(6):784-790.
[30]Craig WR, Hanlon-Dearman A, Sinclair C, Taback S, Moffatt M. Metoclopramide, thickened feedings, and positioning for gastrooesophageal reflux in children under two years [J]. Cochrane Databaes Syst Rev, 2004, 18(4): CD003502.
[31]Omari T.GastroesopHageal reflux in infants: can a simple left side positioning strategy help this diagnostic and therapeutic conundrum? [J]. Minerva Pediatr, 2008, 60(2):193-200.
[32]Horvath A, Dziechciarz P, Szajewska H. The effect of thickened-feed interventions on gastroesophageal reflux in infants: systematic review and Meta-analysis of randomized, controlled trials [J]. Pediatrics, 2008, 122(6):e1268-e1277.
[33]Miyazawa R, Tomomasa T, Kaneko H, Arakawa H, Shimizu N, Morikawa A. Effects of pectin liquid on gastroesophageal reflux disease in children with cerebral palsy [J]. BMC Gastroenterol, 2008, 168:11.
[34]Semeniuk J, Kaczmarski M. Acid gastroesophageal reflux and intensity of symptoms in children with gastroesophageal reflux disease. Comparison of primary gastroesophageal reflux and gastroesophageal reflux secondary to food allergy [J]. Adv Med Sci, 2008, 53(2):293-299.
[35]Hibbs AM, Lorch SA. Metoclopramide for the treatment of gastroesophageal reflux disease in infants: a systematic review [J]. Pediatrics, 2006, 118(2):746-752.
[36]Cresi F, Marinaccio C, Russo MC, Miniero R, Silvestro L. Short-term effect of domperidone on gastroesophageal reflux in newborns assessed by combined intraluminal impedance and pH monitoring [J]. J Perinatol, 2008, 28(11):766-770.
[37]Chicella MF, Batres LA, Heesters MS, Dice JE.Prokinetic drug therapy in children: a review of current options [J].Ann Pharmacother, 2005, 39(4):706-711.
[38]Bishop J, Furman M, Thomson M.Omeprazole for gastroesophageal reflux disease in the first 2 years of life: a dose-finding study with dual-channel pH monitoring [J]. J Pediatr Gastroenterol Nutr, 2007, 45(1):50-55.
[39]Orel R, Brecej J, Homan M, Heuschkel R.Treatment of oesophageal bile reflux in children: the results of a prospective study with omeprazole [J]. J Pediatr Gastroenterol Nutr, 2006, 42(4):376-383.
[40]Gilger MA, Tolia V, Vandenplas Y, Youssef NN, Traxler B, Illueca M.Safety and tolerability of esomeprazole in children with gastroesophageal reflux disease [J].J Pediatr Gastroenterol Nutr, 2008, 46(5):524-533.
[41]Tolia V, Bishop PR, Tsou VM, Gremse D, Soffer EF, Comer GM et al. Multicenter, randomized, double-blind study comparing 10, 20 and 40 mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease [J]. J Pediatr Gastroenterol Nutr, 2006, 42(4):384-391.
[42]James L ,Walson P, Lomax K, Kao R, Varughese S, Reyes J, et al. Pharmacokinetics and tolerability of rabeprazole sodium in subjects aged 12 to 16 years with gastroesophageal reflux disease: An open-label, single-and multiple-dose study [J]. Clin Ther, 2007, 29(9):2082-2092.